16
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Serum Mrp 8/14 as a Potential Biomarker for Predicting the Occurrence of Acute Respiratory Distress Syndrome Induced by Sepsis: A Retrospective Controlled Study

ORCID Icon, , , , , , , & show all
Pages 2939-2949 | Received 02 Jan 2024, Accepted 08 May 2024, Published online: 14 May 2024

References

  • Cecconi M, Evans L, Levy M, et al. Sepsis and septic shock. Lancet. 2018;392(10141):75–87. doi:10.1016/S0140-6736(18)30696-2
  • Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol. 2021;18(6):424–434. doi:10.1038/s41569-020-00492-2
  • Hwang JS, Kim KH, Park J, et al. Glucosamine improves survival in a mouse model of sepsis and attenuates sepsis-induced lung injury and inflammation. J Biol Chem. 2019;294(2):608–622. doi:10.1074/jbc.RA118.004638
  • Hu Q, Hao C, Tang S. From sepsis to acute respiratory distress syndrome (ARDS): emerging preventive strategies based on molecular and genetic researches. Biosci Rep. 2020;40(5):BSR20200830. doi:10.1042/BSR20200830
  • Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788–800. doi:10.1001/jama.2016.0291
  • Auriemma CL, Zhuo H, Delucchi K, et al. Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis. Intensive Care Med. 2020;46(6):1222–1231. doi:10.1007/s00134-020-06010-9
  • Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364(14):1293–1304. doi:10.1056/NEJMoa1011802
  • Cheung AM, Tansey CM, Tomlinson G, et al. Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2006;174(5):538–544. doi:10.1164/rccm.200505-693OC
  • Ranieri VM, Rubenfeld GD, Taylor Thompson B, et al.; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533. doi:10.1001/jama.2012.5669
  • De Freitas Caires N, Gaudet A, Portier L, et al. Endocan, sepsis, pneumonia, and acute respiratory distress syndrome. Crit Care. 2018;22(1):280. doi:10.1186/s13054-018-2222-7
  • Toner P, McAuley DF, Shyamsundar M. Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome. Crit Care. 2015;19:374. doi:10.1186/s13054-015-1091-6
  • Asaduzzaman M, Zhang S, Lavasani S, et al. LFA-1 and MAC-1 mediate pulmonary recruitment of neutrophils and tissue damage in abdominal sepsis. Shock. 2008;30(3):254–259. doi:10.1097/shk.0b013e318162c567
  • Zhang S, Rahman M, Zhang S, et al. Simvastatin antagonizes CD40L secretion, CXC chemokine formation, and pulmonary infiltration of neutrophils in abdominal sepsis. J Leukoc Biol. 2011;89(5):735–742. doi:10.1189/jlb.0510279
  • Vogl T, Gharibyan AL, Morozova-Roche LA. Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes. Int J Mol Sci. 2012;13(3):2893–2917. doi:10.3390/ijms13032893
  • Ding Z, Du F, Averitt VRG, et al. Targeting S100A9 Reduces Neutrophil Recruitment, Inflammation and Lung Damage in Abdominal Sepsis. Int J Mol Sci. 2021;22(23):12923. doi:10.3390/ijms222312923
  • Zhao B, Lu R, Chen J, et al. S100A9 blockade prevents lipopolysaccharide-induced lung injury via suppressing the NLRP3 pathway. Respir Res. 2021;22(1):45. doi:10.1186/s12931-021-01641-y
  • Lee A, Nahm CH, Lee JS, et al. Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19. J Clin Lab Anal. 2021;35(11):e24004. doi:10.1002/jcla.24004
  • Kassianidis G, Siampanos A, Poulakou G, et al. Calprotectin and Imbalances between acute-phase mediators are associated with critical illness in COVID-19. Int J Mol Sci. 2022;23(9):4894. doi:10.3390/ijms23094894
  • Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377. doi:10.1007/s00134-017-4683-6
  • Steck P, Ritzmann F, Honecker A, et al. Interleukin 17 receptor E (IL-17RE) and IL-17C mediate the recruitment of neutrophils during acute streptococcus pneumoniae Pneumonia. Infect Immun. 2019;87(11):e00329–19. doi:10.1128/IAI.00329-19
  • Wang P, Hou Y, Zhang W, et al. Pseudoginsenoside-F11 attenuates lipopolysaccharide-induced acute lung injury by suppressing neutrophil infiltration and accelerating neutrophil clearance. Inflammation. 2019;42(5):1857–1868. doi:10.1007/s10753-019-01047-5
  • Kim ND, Luster AD. The role of tissue resident cells in neutrophil recruitment. Trends Immunol. 2015;36(9):547–555. doi:10.1016/j.it.2015.07.007
  • Schenten V, Plançon S, Jung N, et al. Secretion of the Phosphorylated Form of S100A9 from neutrophils is essential for the proinflammatory functions of extracellular Mrp 8/14. Front Immunol. 2018;9:447. doi:10.3389/fimmu.2018.00447
  • Kovačić M, Mitrović-Ajtić O, Beleslin-čokić B, et al. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms. Cell Oncol. 2018;41(5):541–553. doi:10.1007/s13402-018-0392-6
  • Revenstorff J, Ludwig N, Hilger A, et al. Role of Mrp 8/14 in platelet-neutrophil complex formation during acute inflammation. Cells. 2022;11(23):3944. doi:10.3390/cells11233944
  • Pierrakos C, Velissaris D, Bisdorff M, et al. Biomarkers of sepsis: time for a reappraisal. Crit Care. 2020;24(1):287. doi:10.1186/s13054-020-02993-5
  • McFadyen JD, Zeller J, Potempa LA, et al. C-reactive protein and its structural isoforms: an evolutionary conserved marker and central player in inflammatory diseases and beyond. Subcell Biochem. 2020;94:499–520. doi:10.1007/978-3-030-41769-7_20
  • Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426–435. doi:10.1016/S1473-3099(12)70323-7
  • Klouche K, Cristol JP, Devin J, et al. Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients. Ann Intensive Care. 2016;6(1):59. doi:10.1186/s13613-016-0160-6
  • Ma L, Zhang H, Yin YL, et al. Role of interleukin-6 to differentiate sepsis from non-infectious systemic inflammatory response syndrome. Cytokine. 2016;88:126–135. doi:10.1016/j.cyto.2016.08.033
  • Takahashi W, Nakada TA, Yazaki M, et al. Interleukin-6 levels act as a diagnostic marker for infection and a prognostic marker in patients with organ dysfunction in intensive care units. Shock. 2016;46(3):254–260. doi:10.1097/SHK.0000000000000616
  • Zhang D, Tang Z, Huang H, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575–580. doi:10.1038/s41586-019-1678-1
  • Murray CK, Hoffmaster RM, Schmit DR, et al. Evaluation of white blood cell count, neutrophil percentage, and elevated temperature as predictors of bloodstream infection in burn patients. Arch Surg. 2007;142(7):639–642. doi:10.1001/archsurg.142.7.639
  • AlRawahi AN, AlHinai FA, Doig CJ, et al. The prognostic value of serum procalcitonin measurements in critically injured patients: a systematic review. Crit Care. 2019;23(1):390. doi:10.1186/s13054-019-2669-1
  • Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206–217. doi:10.1086/421997
  • Hamed S, Behnes M, Pauly D, et al. Diagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions. BMC Infect Dis. 2017;17(1):554. doi:10.1186/s12879-017-2606-3
  • Matthay MA, Arabi Y, Arroliga AC, et al. A new global definition of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2023. doi:10.1164/rccm.202303-0558WS